Voice disorders associated with novel coronavirus infection

Kryshtopava M.A.; Alenskaya T.L.; Azaronak M.K.; Petrova L.G.

doi:https://doi.org/10.17116/otorino20238806130

Close metadata

OBJECTIVE

To evaluate the features of voice disorders associated with novel coronavirus infection and to develop the clinical algorithm for diagnostic and treatment these patients.

MATERIAL AND METHODS

A prospective observational study was conducted in patients with dysphonia after COVID-19 (n=60). All patients underwent a comprehensive voice assessment before and after the proposed treatment. The follow-up period was 1 month.

RESULTS

Functional dysphonia or aphonia with a stable (refractory) or recurrent course was diagnosed in 58 (97%) patients. A tendency to an increase in the value of the latent period of the P300 and MMN in patients with voice disorder was revealed. There was a significant decrease in supraglottic constriction and glottal insufficiency before and after the treatment. The mean VHI-10 decreased from 25.4 before treatment to 15.3 after treatment. The DSI which is based on the set of voice measurements, statistically significant improved from –5.2 to 2.6 in patients as a result of treatment. The average value of MFI-20 improved from 65.4 (8.7) at the beginning of the study to 20.3 (5.3) after treatment.

CONCLUSION

In patients with dysphonia or aphonia associated with COVID-19 are indicated a refractory type of dysphonia. This was indicated by the study of AEPs of the brain. The clinical algorithm for treatment and diagnostic patients with voice disorders after COVID-19 has been developed. The treatment of this group of patients should be adjunct by the drug therapy, kinesiotaping method and psychotherapy.

Keywords:

dysphonia

COVID-19

post-COVID-19

kinesiotaping method

auditory evoked potentials

AEPs

dysphonia severity index

DSI

P300

MMN

Authors:

Kryshtopava M.A.

Vitebsk State Order of Friendship of Peoples Medical University

ORCID: 0000-0002-5997-8260

Alenskaya T.L.

Vitebsk State Order of Friendship of Peoples Medical University

ORCID: 0000-0001-5637-0631

Azaronak M.K.

Vitebsk State Order of Friendship of Peoples Medical University

ORCID: 0000-0003-2235-4603

Petrova L.G.

Belarusian Medical Academy of Postgraduate Education

ORCID: 0000-0003-0353-553X

Received:

23.09.2022

Accepted:

20.03.2023

Close metadata

References:

Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372. https://doi.org/10.1136/bmj.n136
Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li L-J, Zeng G, Yuen K-Y, Chen R-C, Tang C-L, Wang T, Chen P-Y, Xiang J, Li S-Y, Wang JL, Liang Z-J, Peng Y-X, Wei L, Liu Y, Hu Y-H, Peng P, Wang J-M, Liu J-Y, Chen Z, Li G, Zheng Z-J, Qiu SQ, Luo J, Ye C-J, Zhu S-Y, Zhong N-S; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. https://doi.org/10.1056/NEJMoa2002032
Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. European Archives of Oto-Rhino-Laryngology. 2020;277(7):1885-1897. https://doi.org/10.1007/s00405-020-05968-y
Krishtopova MA, Petrova LG, Semenov SA, Kulyakin EV, Chukhol’skaya NA. Ent manifestations in patients with COVID-19. Otorinolaringologiya. Vostochnaya Evropa. 2021;11(1):8-17. (In Russ.). https://doi.org/10.34883/PI.2021.11.1.037
Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis. Clinical Otolaryngology. 2020;45(6):914-922. https://doi.org/10.1111/coa.13620
O’Donovan J, Tanveer S, Jones N, Hopkins C, Senior BA, Wise SK, Brassey J, Greenhalgh T. What is the evidence for anosmia (loss of smell) as a clinical feature of COVID-19. The Center for Evidence-Based Medicine. 2020. Accessed September 18, 2023. https://www.cebm.net/covid-19/what-is-the-evidence-for-anosmia-loss-of-smell-as-a-clinical-feature-of-covid-19/
Klopfenstein T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, Royer PY, Toko L, Gendrin V, Zayet S. New loss of smell and taste: Uncommon symptoms in COVID-19 patients in Nord Franche-Comte cluster, France. International Journal of Infectious Diseases. 2020;100:117-122. https://doi.org/10.1016/j.ijid.2020.08.012
Rassekh CH, Jenks CM, Ochroch EA, Douglas JE, O’Malley BW Jr, Weinstein GS. Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario. Head and Neck. 2020;42(6):1273-1277. https://doi.org/10.1002/hed.26175
Archer SK, Iezzi CM, Gilpin L. Swallowing and voice outcomes in patients hospitalized with COVID-19: An observational cohort study. Archives of Physical Medicine and Rehabilitation. 2021;102(6):1084-1090. https://doi.org/10.1016/j.apmr.2021.01.063
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, Huang H, Li C. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Investigative Radiology. 2020;55(5):257. https://doi.org/10.1097/RLI.0000000000000670
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. https://doi.org/10.1001/jama.2020.1585
Barillari MR, Bastiani L, Lechien JR, Mannelli G, Molteni G, Cantarella G, Coppola N, Costa G, Trecca EMC, Grillo C, La Mantia I, Chiesa-Estomba CM, Vicini C, Saussez S, Nacci A, Cammaroto G. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study. Journal of Medical Virology. 2021;93(2):983-994. https://doi.org/10.1002/jmv.26354
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280. e8. https://doi.org/10.1016/j.cell.2020.02.052
Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605. https://doi.org/10.1001/jama.2020.12603
Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterology and Motility. 2021;33(3):e14104. https://doi.org/10.1111/nmo.14104
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March-June 2020. Morbidity and Mortality Weekly Report. 2020;69(30):993. https://doi.org/10.15585/mmwr.mm6930e1
Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019
Chakraborty T, Jamal RF, Battineni G, Teja KV, Marto CM, Spagnuolo G. A review of prolonged post-Covid-19 symptoms and their implications on dental management. International Journal of Environmental Research and Public Health. 2021;18(10): 5131. https://doi.org/10.3390/ijerph18105131
Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post- Covid syndrome: A systematic review and meta-analysis. eClinicalMedicine. 2021;36:100899. https://doi.org/10.1016/j.eclinm.2021.100899
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373. https://doi.org/10.1136/bmj.n1098
Jiang G, Cai Y, Yi X, Li Y, Lin Y, Li Q, Xu J, Ke M, Xue K. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study. Journal of Medical Virology. 2020;92(10):2124-2129. https://doi.org/10.1002/jmv.25998
Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, Flament T, Ferreira-Maldent N, Bruyère F, Stefic K, Gaudy-Graffin C, Grammatico-Guillon L, Bernard L. Follow-up of adults with non-critical Covid-19 two months after symptoms’ onset. Clinical Microbiol and Infection. 2021;27(2):258-263. https://doi:10.1016/j.cmi.2020.09.052
Postanovlenie Ministerstva zdravookhraneniya Respubliki Belarus’ ot 1 iyunya 2017 g. №49 «Ob utverzhdenii klinicheskogo protokola «Diagnostika i lechenie patsientov s otorinolaringologicheskimi zabolevaniyami (vzrosloe naselenie)». (In Russ.). Accessed April 29, 2023. https://pravo.by/document/?guid=3961&p0=W21732110p
Kryshtopava MA, Osipuk ES, Semenov SA, Petrova LG. Linguistic Adaptation and Validation of the Voice Handicap Index (VHI)-10 into Russian in Patients with Dysphonia. Otorinolaringologiya. Vostochnaya Evropa. 2020;10(3):223-234. (In Russ.).
Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research. 1995;39(3):315-325. https://doi.org/10.1016/0022-3999(94)00125-o
Krishtopova MA. Narusheniya golosa u patsientov s SOVID-19. Meditsinskij vestnik. Informatsionnyj portal medrabotnikov Belarusi. (In Russ.). Accessed September 18, 2023. https://medvestnik.by/konspektvracha/narusheniya-golosa-u-patsientov-s-sovid-19
Yamauchi EJ, Imaizumi S, Maruyama H, Haji T. Perceptual evaluation of pathological voice quality: A comparative analysis between the RASATI and GRBASI scales. Logopedics, Phoniatrics, Vocology. 2010;35(3):121-128. https://doi.org/10.3109/14015430903334269
Morrison MD, Rammage LA. Muscle misuse voice disorders: description and classification. Acta Oto-Laryngologica. 1993;113(3):428-434. https://doi.org/10.3109/00016489309135839
Koufman JA, Blalock PD. Functional voice disorders. Otolaryngologic Clinics of North America. 1991;24(5):1059-1073.
Wuyts FL, De Bodt MS, Molenberghs G, Remacle M, Heylen L, Millet B, Van Lierde K, Raes J, Van de Heyning PH. The dysphonia severity index: an objective measure of vocal quality based on a multiparameter approach. Journal of Speech, Language, and Hearing Research. 2000;43(3):796-809. https://doi.org/10.1044/jslhr.4303.796
Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, Greene M, Miller BL, Annan W, Henrich TJ, Peluso MJ. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. Journal of Neurovirology. 2021;27(1):191-195. https://doi.org/10.1007/s13365-021-00954-4
Lechien JR, Chiesa-Estomba CM, Cabaraux P, Mat Q, Huet K, Harmegnies B, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Hans S, Crevier-Buchman L, Hochet B, Distinguin L, Chekkoury-Idrissi Y, Circiu M, El Afia F, Barillari MR, Cammaroto G, Fakhry N, Michel J, Radulesco T, Martiny D, Lavigne P, Jouffe L, Descamps G, Journe F, Trecca EMC, Hsieh J, Delgado IL, Calvo-Henriquez C, Vergez S, Khalife M, Molteni G, Mannelli G, Cantarella G, Tucciarone M, Souchay C, Leich P, Ayad T, Saussez S. Features of mild-to-moderate COVID-19 patients with dysphonia. Journal of Voice. 2022;36(2):249-255. https://doi.org/10.1016/j.jvoice.2020.05.012
Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, Rosaria Barillari M, Cammaroto G, Fakhry N, Martiny D, Ayad T, Jouffe L, Hopkins C, Saussez S; COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine. 2020;288(3):335-344. https://doi.org/10.1111/joim.13089
Cantarella G, Aldè M, Consonni D, Zuccotti G, Berardino FD, Barozzi S, Bertoli S, Battezzati A, Zanetti D, Pignataro L. Prevalence of Dysphonia in Non hospitalized Patients with COVID-19 in Lombardy, the Italian Epicenter of the Pandemic. Journal of Voice. 2023;37(4):605-609. https://doi.org/10.1016/j.jvoice.2021.03.009
Bennett J, Dolin R, Blaser MJ. Principles and Practice of Infectious Diseases. Saunders, PA, USA: Elsevier; 2014.
Johnston GR, Webster NR. Cytokines and the immunomodulatory function of the vagus nerve. British Journal of Anaesthesia. 2009;102(4):453-462. https://doi.org/10.1093/bja/aep037
Köller H, Siebler M, Hartung HP. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Progress in Neurobiology. 1997;52(1):1-26. https://doi.org/10.1016/s0301-0082(96)00065-2
Kryshtopava M, Van Lierde K, Meerschman I, D’Haeseleer E, Vandemaele P, Vingerhoets G, Claeys S. Brain activity during phonation in women with muscle tension dysphonia: An fMRI study. Journal of Voice. 2017;31(6)675-690. https://doi.org/10.1016/j.jvoice.2017.03.010
Buselli R, Corsi M, Necciari G, Pistolesi P, Baldanzi S, Chiumiento M, Del Lupo E, Guerra PD, Cristaudo A. Sudden and persistent dysphonia within the framework of COVID-19: the case report of a nurse. Brain, Behavior, and Immunity-Health. 2020;9:100160. https://doi.org/10.1016/j.bbih.2020.100160
Martins RH, Tavares EL, Ranalli PF, Branco A, Pessin AB. Psychogenic dysphonia: diversity of clinical and vocal manifestations in a case series. Brazilian Journal of Otorhinolaryngology. 2014;80(6):497-502. https://doi.org/10.1016/j.bjorl.2014.09.002